Agile Therapeutics Inc (AGRX)


Stock Price Forecast

Feb. 29, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Agile Therapeutics Inc chart...

About the Company

agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.

$19M

Total Revenue

44

Employees

$2M

Market Capitalization

-0.15

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AGRX News

Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds

7d ago, source: Business Insider

PRINCETON, N.J., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile Therapeutics” or the “Company”), a women's healthcare company, today announced the entry into a ...

What's Going On With Women Health Focused Agile Therapeutics Stock Today?

6d ago, source: Hosted on MSN

Agile Therapeutics Inc (NASDAQ:AGRX) shares jumped during the trading session on Thursday on a solid volume session volume of ...

Why Agile Therapeutics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket

11mon ago, source: Hosted on MSN

Minim, Inc. (NASDAQ: MINM ... get started now. This article Why Agile Therapeutics Shares Are Trading Higher By Over 14%; Here Are 20 Stocks Moving Premarket originally appeared on Benzinga.com ...

AGXRW Agile Therapeutics, Inc. WT EXP 101326

22d ago, source: Seeking Alpha

**NM signifies a non meaningful value. A dash signifies the data is not available.

Agile Therapeutics Inc AGRX

7d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds

7d ago, source: Yahoo Finance

PRINCETON, N.J., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX) (“Agile Therapeutics” or the “Company”), a women's healthcare company, today announced the entry ...

Agile Therapeutics, Inc.

3y ago, source: CNN

Agile Therapeutics, Inc. is a healthcare company, which engages in the development and commercialization of transdermal patches. Its lead product candidate, Twirla, also known as AG200-15 ...

Agile Therapeutics Inc. Wt

2y ago, source: Wall Street Journal

No significant news for in the past two years. Key Stock Data P/E Ratio (TTM) The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing ...

Agile Therapeutics, Inc. Common Stock (AGRX)

4y ago, source: Nasdaq

NASDAQ, Inc. short interest is available by issuer for the past 12 months and updated twice a month. Short interest data is reported on mid-month and end-of-month settlement dates. It is then ...

Agile Therapeutics Inc AGRX

7d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...